Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Expert Market Research report, titled “Vilazodone (Viibryd) Manufacturing Plant Project Report 2024 Edition: Industry Trends, Capital Investment, Price Trends, Manufacturing Process, Raw Materials Requirement, Plant Setup, Operating Cost, and Revenue Statistics,” provides an in-depth and comprehensive examination of the financial and operational aspects of establishing vilazodone (Viibryd) plant.
The report is the result of extensive primary and secondary research, offering a detailed analysis of current market trends, including the effects of COVID-19 on both global and regional scales. It profiles key industry players, giving insights into their market strategies, production capacities, and financial performance, which are crucial for benchmarking and competitive analysis.
It delves into historical, current, and forecasted price trends, helping stakeholders understand market dynamics and price volatility. The report provides a thorough analysis of the mass balance and raw materials requirements, ensuring a clear understanding of the input-output ratios essential for efficient production. Detailed examinations of the various unit operations integral to the vilazodone (Viibryd) manufacturing process are included, highlighting process optimisation techniques and technological advancements.
The report presents a comprehensive capital cost analysis, detailing the financial investment required for setting up a vilazodone (Viibryd) plant. This includes an exhaustive breakdown of costs associated with raw materials, catchem, utilities, labour, packaging, transportation, land acquisition, construction, and machinery. Additionally, it offers an in-depth look at the operating costs, providing clarity on the recurring expenses involved in running the plant.
Projected profit margins and optimal product pricing strategies are outlined, offering guidance on maximising profitability. The report also addresses regulatory frameworks, environmental impacts, and sustainability measures pertinent to the vilazodone (Viibryd) industry.
Vilazodone (Viibryd) is an antidepressant medication used to treat major depressive disorder in adults. It works by inhibiting serotonin reuptake and partially agonizing 5-HT1A receptors. Viibryd is taken once daily with food. Vilazodone was approved by the FDA in 2011 as a novel antidepressant option. Vilazodone has a boxed warning for an increased risk of suicidal thoughts and behaviours in certain people, especially those under 25. Dosage can range from 10-80 mg/day, depending on individual response and potential drug interactions.
Vilazodone is the active pharmaceutical ingredient (API) in the antidepressant medication Viibryd. The API is a white to cream-colored solid that exists in multiple polymorphic forms, with Form IV chosen for commercial development. It is taken once daily with food, starting at 10 mg and titrating up to 40 mg. Vilazodone has a bioavailability of 72%, an elimination half-life of 25 hours, and a solubility of 0.32 mg/mL in water at 20°C. Common side effects include nausea, diarrhoea, and insomnia, while serious potential side effects involve increased suicidal thoughts, serotonin syndrome, and bleeding. Vilazodone may offer advantages over other antidepressants by causing less emotional blunting.
Key steps in the manufacturing process of Vilazodone include reacting a compound of formula II with a source of ammonia to obtain the Vilazodone base. This base is then converted to its hydrochloride salt form. The Vilazodone active pharmaceutical ingredient (API) is formulated into 10 mg, 20 mg, and 40 mg oral tablets by combining the API with excipients such as microcrystalline cellulose, lactose monohydrate, sodium starch glycolate, magnesium stearate, and Opadry II. Stability studies have been conducted on batches of the API and drug product to support the commercial manufacturing process and formulation. The finished tablets are packaged for distribution as the prescription medication Viibryd.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Step 1: Synthesis of 5-Bromo-1H-indole
1. Starting Materials:
2. Reaction:
Step 2: Synthesis of 5-(4-Chlorobutyl)-1H-indole
1. Starting Materials:
2. Reaction:
Step 3: Synthesis of 5-(4-Chlorobutyl)-1H-indol-3-yl Acetate
1. Starting Materials:
2. Reaction:
Step 4: Synthesis of Vilazodone
1. Starting Materials:
2. Reaction:
Final Product:
Vilazodone (Viibryd), with a chemical formula of C26H27ClN4O2.
Vilazodone (Viibryd) is an antidepressant medication used to treat major depressive disorder (MDD), which is a common and debilitating mental health condition, affecting around 121 million people worldwide. Market analysis indicates the vilazodone/Viibryd market is expected to grow annually with a high growth rate, driven by factors like the high prevalence of depression and the need for new treatment options.
This production cost analysis report by Expert Market Research scrutinises the vilazodone (Viibryd) manufacturing process, offering a comprehensive overview necessary for stakeholders considering venturing into this sector. Based on the latest economic data, the report encompasses detailed insights into the primary process flow, raw material requirements, reactions involved, utility costs, operating costs, capital investments, pricing strategies, and profit margins. This report is an indispensable resource for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake in the vilazodone (Viibryd) industry. It equips them with essential information and strategic insights to effectively navigate the complexities of the market.
The following sections detail the comprehensive scope of the prefeasibility report for a vilazodone (Viibryd) production plant:
This prefeasibility report aims to equip potential investors and existing manufacturers with crucial insights to make informed decisions in the vilazodone (Viibryd) industry.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124